MOMEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MOMEDIC
Largest movements
- Cash -€268,736
down €268,736 (-92.4%), from €290,924 to €22,187
mainly Contributions, distributions and other (-€379,415) and Other debts (-€226,971)
- Tangible fixed assets -€15,003
down €15,003 (-51.4%), from €29,205 to €14,202
- Other debts -€226,971
down €226,971 (-72.6%), from €312,753 to €85,782
- Tax, wage and social debts -€50,864
no longer reported in 2025 (was €50,864)
- Gross operating margin +€49,890
up €49,890 (+10.6%), from €471,060 to €520,950
- Taxes +€12,859
up €12,859 (+11.6%), from €111,301 to €124,160
- Depreciation -€6,729
down €6,729 (-28.6%), from €23,562 to €16,833
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €637,780 | €360,024 | -€277,755 | -43.6% |
| Fixed assets | 21/28 | €29,205 | €14,202 | -€15,003 | -51.4% |
| Tangible fixed assets | 22/27 | €29,205 | €14,202 | -€15,003 | -51.4% |
| Furniture and vehicles | 24 | €29,205 | €14,202 | -€15,003 | -51.4% |
| Current assets | 29/58 | €608,575 | €345,823 | -€262,752 | -43.2% |
| Amounts receivable after more than one year | 29 | €150,000 | €150,000 | = | 0.0% |
| Other amounts receivable | 291 | €150,000 | €150,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €167,651 | €173,635 | +€5,984 | +3.6% |
| Trade receivables | 40 | €167,651 | €172,666 | +€5,015 | +3.0% |
| Other amounts receivable | 41 | - | €970 | +€970 | |
| Cash at bank and in hand | 54/58 | €290,924 | €22,187 | -€268,736 | -92.4% |
| Total equity and liabilities | 10/49 | €637,780 | €360,024 | -€277,755 | -43.6% |
| Equity | 10/15 | €274,053 | €274,053 | = | 0.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €255,453 | €255,453 | = | 0.0% |
| Distributable reserves | 133 | €255,453 | €255,453 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €363,726 | €85,971 | -€277,755 | -76.4% |
| Amounts payable within one year | 42/48 | €363,726 | €85,971 | -€277,755 | -76.4% |
| Trade debts | 44 | €109 | €189 | +€80 | +73.3% |
| Suppliers | 440/4 | €109 | €189 | +€80 | +73.3% |
| Taxes, remuneration and social security | 45 | €50,864 | - | -€50,864 | |
| Taxes | 450/3 | €50,864 | - | -€50,864 | |
| Other amounts payable | 47/48 | €312,753 | €85,782 | -€226,971 | -72.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €23,562 | €16,833 | -€6,729 | -28.6% |
| Other operating charges | 640/8 | €482 | €495 | +€12 | +2.6% |
| Gross operating margin | 9900 | €471,060 | €520,950 | +€49,890 | +10.6% |
| Operating profit (loss) | 9901 | €447,016 | €503,622 | +€56,607 | +12.7% |
| Financial charges | 65/66B | €47 | €48 | +€2 | +3.2% |
| Recurring financial charges | 65 | €47 | €48 | +€2 | +3.2% |
| Profit (loss) for the period before taxes | 9903 | €446,969 | €503,574 | +€56,605 | +12.7% |
| Income taxes | 67/77 | €111,301 | €124,160 | +€12,859 | +11.6% |
| Profit (loss) for the period | 9904 | €335,668 | €379,415 | +€43,746 | +13.0% |
| Profit (loss) for the period to be appropriated | 9905 | €335,668 | €379,415 | +€43,746 | +13.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.